Voyager Therapeutics, Inc.

Voyager Therapeutics is a biotechnology company focused on developing gene therapies for neurological diseases, aiming to modify the course and ultimately cure these conditions. Their approach involves targeting the underlying genetic causes of these diseases, utilizing their TRACER™ AAV capsid discovery platform to develop novel capsids that can efficiently cross the blood-brain barrier and deliver therapeutic agents to the central nervous system. This innovative platform allows for intravenous administration, minimizing invasiveness compared to traditional methods.

Voyager's pipeline includes several promising candidates in various stages of development, targeting diseases like Alzheimer's, ALS, Parkinson's, and Friedreich's Ataxia. They collaborate with other pharmaceutical companies to leverage their expertise and expand the reach of their technology, ultimately aiming to create transformative treatments for millions of people living with neurological diseases.

Voyager Therapeutics offers unlimited vacation time, which is an attractive benefit for employees seeking flexibility in their schedules. While specific details about remote work arrangements are not mentioned, the company's focus on employee well-being and a "Better Together" core value suggest a supportive environment for flexible work options.

Voyager Therapeutics offers a comprehensive benefits package that prioritizes the health and well-being of employees and their families. The package includes a robust healthcare plan with a Health Reimbursement Arrangement covering deductibles, fitness program reimbursements, mental health programming, dental and vision insurance, flexible spending accounts for healthcare and childcare expenses, an employee assistance program, and an on-site gym at their Lexington location.

Voyager Therapeutics is a biotechnology company focused on developing disease-modifying neurogenetic medicines to treat neurological diseases. They aim to achieve this by identifying validated targets, advancing multiple therapeutic modalities, and delivering these therapies to the right areas within the central nervous system. Their goal is to create a world where transformative treatments and cures are available for the millions affected by these devastating conditions.

Voyager Therapeutics fosters a culture of innovation and collaboration, where dedicated professionals are empowered to push boundaries in the pursuit of transformative neurogenetic medicines. Their core values emphasize putting patients first, valuing teamwork, embracing bold exploration, and ensuring accountability for achieving meaningful progress.

Voyager Therapeutics is committed to fostering a diverse and inclusive workplace where all individuals are treated with respect and dignity. They believe that diversity strengthens their organization and contributes to their success, embracing the unique perspectives and talents that each individual brings. They are eager to learn more about identities that vary by race, ethnicity, social background, religion, gender, age, disability, sexual orientation, veteran status, and national origin, recognizing that diversity is inherently intersectional.